SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-050760
Filing Date
2021-04-15
Accepted
2021-04-15 16:03:21
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2112964d1_s3.htm S-3 281997
2 EXHIBIT 5.1 tm2112964d1_ex5-1.htm EX-5.1 9523
3 EXHIBIT 10.3 tm2112964d1_ex10-3.htm EX-10.3 140990
4 EXHIBIT 23.1 tm2112964d1_ex23-1.htm EX-23.1 4433
5 EXHIBIT 23.2 tm2112964d1_ex23-2.htm EX-23.2 3753
6 GRAPHIC image_001.jpg GRAPHIC 3599
7 GRAPHIC image_002.jpg GRAPHIC 3599
8 GRAPHIC image_003.jpg GRAPHIC 14407
9 GRAPHIC image_004.jpg GRAPHIC 3577
  Complete submission text file 0001104659-21-050760.txt   477074
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-255249 | Film No.: 21828510
SIC: 2834 Pharmaceutical Preparations